PACS Group, Inc. (PACS)
| Market Cap | 5.21B |
| Revenue (ttm) | 5.29B |
| Net Income (ttm) | 191.54M |
| Shares Out | 157.17M |
| EPS (ttm) | 1.22 |
| PE Ratio | 27.16 |
| Forward PE | 15.76 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,156,148 |
| Open | 34.40 |
| Previous Close | 35.27 |
| Day's Range | 32.26 - 34.83 |
| 52-Week Range | 7.50 - 43.08 |
| Beta | 0.06 |
| Analysts | Strong Buy |
| Price Target | 45.50 (+37.3%) |
| Earnings Date | Feb 26, 2026 |
About PACS
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah. [Read more]
Financial Performance
In 2025, PACS Group's revenue was $5.29 billion, an increase of 29.32% compared to the previous year's $4.09 billion. Earnings were $191.54 million, an increase of 243.51%.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for PACS stock is "Strong Buy." The 12-month stock price target is $45.5, which is an increase of 37.30% from the latest price.
News
PACS Group, Inc. Announces the Appointment of Carey P. Hendrickson as Chief Financial Officer
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson...
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the planned retirement of Mark Hancock ...
PACS Group Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference
The organization reported record growth in 2025, driven by a mission-focused model, high occupancy, and strong financials. Despite ongoing government investigations, leadership emphasized operational strength, robust M&A opportunities, and optimistic guidance for 2026.
PACS Group, Inc. to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United State...
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Patrick H. Conway, M...
PACS Group Earnings Call Transcript: Q4 2025
Record 2025 results driven by strong integration, occupancy, and clinical quality, with revenue up 29% and adjusted EBITDA reaching $505M. 2026 guidance targets 8% revenue and 12% EBITDA growth, supported by disciplined acquisitions and a robust pipeline.
PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United State...
PACS Group Intends to Release Fiscal Year and Fourth Quarter 2025 Earnings on February 26, 2026
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United State...
PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced that independently operated subsidiaries of the Company have acquired the operations of three p...
PACS Group Transcript: 44th Annual J.P. Morgan Healthcare Conference
The group detailed its mission-driven, decentralized approach to post-acute care, emphasizing growth through acquisition and operational turnaround of underperforming facilities. Strong financials, a robust M&A pipeline, and a focus on higher acuity patients position it for continued expansion and innovation, with AI as a future differentiator.
PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 5:15 p.m.
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) announced today that Jason Murray, Chairman and Chief Executive Officer, and Mark Hancock, Executive Vice President and Interim Chief Fin...
PACS Group Expands Management Team, Adding New Chief Compliance Officer and Chief Human Resource Officer to Executive Leadership Team
FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United Sta...
PACS Group Announces Business Updates
FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United Sta...
PACS Group Earnings Call Transcript: Q3 2025
Record revenue and adjusted EBITDA were achieved in Q3 and year-to-date 2025, driven by strong operational execution, portfolio expansion, and high occupancy rates. Full-year 2025 guidance projects 30% revenue growth and record adjusted EBITDA, with disciplined capital allocation and a focus on quality care.
PACS Group, Inc. Reports Third Quarter 2025 Results
FARMINGTON, Utah--(BUSINESS WIRE)--PACS announced operating results for the third quarter of 2025. PACS has completed its Restatement of financials and is current with SEC obligations.
PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025
FARMINGTON, Utah--(BUSINESS WIRE)--PACS will release its third quarter 2025 earnings and file its outstanding annual and quarterly filings through Sept 30, 2025 on Weds, Nov 19, 2025.
PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics
FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), on September 10, 2025, announced that on September 9, 2025, the New York Stock Exchange (“NYSE”) Listing Ope...
Fox, PACS Group, News Corp And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.1% on Tuesday.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Shareholders to Reach Out
NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:...
PACS Group to Restate Certain Previously Issued Financial Statements
FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it will restate its previously issued condensed combined/consolidated financial statemen...
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Shareholders to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:...
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Stockholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:...
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Investors to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:...
INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of PACS Group, Inc. and Encourages Long-Term Investors to Contact the Firm - PACS
PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning PACS Group, Inc. (NYSE:PACS) ("PACS") on beh...
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:P...